Latest News for: MDS

Edit

NBEMS announces NEET PG and NEET MDS 2026 exam dates, check notice here

Hindustan Times 23 Jan 2026
... NEET MDS 2026 exam dates.
Edit

National Medical Exam board releases NEET PG, NEET MDS 2026 exam dates

India Today 23 Jan 2026
National Medical Exam board releases NEET PG NEET MDS exam dates ... .
Edit

NBEMS releases exam schedules for NEET PG, & MDS 2026

Indian Express 22 Jan 2026
The NEET-PG 2026 is ...
Edit

NEET PG and NEET MDS 2026: NBEMS releases tentative exam dates and eligibility details

The Economic Times 22 Jan 2026
... has released the tentative exam dates for NEET-PG and NEET-MDS 2026.
Edit

NEET MDS, PG Exams 2026 Tentative Schedule Released, Check Details Here

NDTV 22 Jan 2026
NEET MDS, PG Exams 2026. The examinations are conducted annually for admission to postgraduate medical and dental courses across India ... .
Edit

NEET PG, MDS 2026 exam schedule declared: Check important dates here

The Times of India 22 Jan 2026
The National Board of Examinations in Medical Sciences (NBEMS) has released the tentative schedule for NEET-PG 2026 and NEET-MDS 2026, two of India’s most significant postgraduate medical entrance exams.
Edit

CMS Begins SNF MDS Data Validation Process (LeadingAge Texas)

Public Technologies 15 Jan 2026
CMS Begins SNF MDS Data Validation Process. Home» CMS Begins SNF MDS Data Validation Process ... The selected SNFs will be notified through iQIES and will be required to provide medical records to support coding on up to 10 selected MDS assessments.
Edit

AdC adopted a non-opposition decision in concentration operation 95/2025 - MDS / Seguramos (Portuguese Competition Authority)

Public Technologies 13 Jan 2026
) 13-01-2026. AdC adopted a non-opposition decision in concentration operation 95/2025 - MDS / Seguramos ... 1 of article 19 of the Statutes, approved by Decree-Law No ... Case File. Case File. Share ... Disclaimer.
Edit

Gujarat govt transfers 26 IAS officers including MDs of GNFC & GSPC

Business Line 23 Dec 2025
Avantika Singh Aulakh, ...
Edit

White coat ceremony for new BDS & MDS students at PU dental institute

The Times of India 11 Dec 2025
+Text SizeSmallMediumLarge. .
Edit

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition (Form 8-K) (Rigel Pharmaceuticals Inc)

Public Technologies 10 Dec 2025
"New therapies are needed for patients with transfusion dependent lower-risk MDS ... R289 was generally well tolerated across all dose groups in this heavily pre-treated lower-risk MDS patient population, the majority of whom were HTB at baseline.
Edit

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

Image Missoulian 09 Dec 2025
– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement – ... .
Edit

Celebrating a Milestone: The 10th Annual MDS-PAS Movement Disorders School (The Michael J Fox Foundation for Parkinson's Research)

Public Technologies 09 Dec 2025
Safra Foundation sponsored the International Parkinson and Movement Disorder Society Pan American Section (MDS-PAS) 10th annual Movement Disorders School for Neurology Residents, held in Denver this September ... Disclaimer.
Edit

Correlation between Treatment-Emergent Cytopenias and Clinical Response with Imetelstat (IME) in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS): Analysis from the IMerge Trial (Geron Corporation)

Public Technologies 08 Dec 2025
ANC, absolute neutrophil count; LR, lower risk; MDS, myelodysplastic syndromes; RBC, red blood cell; TEAE, treatment-emergent adverse event; TI, transfusion independence ... IPSS low- or INT-1-risk MDS ... IPSS low- or INT-1-risk MDS.
Edit

Faron Presents Updated BEXMAB Data at ASH 2025: Deep and Durable Responses in HR-MDS with Favorable Safety Profile

Pharmiweb 08 Dec 2025
TURKU, FI / ACCESS Newswire / December 8, 2025 / Faron Pharmaceuticals (HEL.FARON)(LSE.FARN) - Significant efficacy observed in TP53-mutated patients with a 70% complete remission rate in the frontline HR MDS.

Article Search

tools
×
×
×
×